1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
